Below are the most recent publications written about "Death, Sudden, Cardiac" by people in Profiles.
-
Stabenau HF, Sau A, Kramer DB, Peters NS, Ng FS, Waks JW. Limits of the spatial ventricular gradient and QRST angles in patients with normal electrocardiograms and no known cardiovascular disease stratified by age, sex, and race. J Cardiovasc Electrophysiol. 2023 11; 34(11):2305-2315.
-
Milman A, Sabbag A, Conte G, Postema PG, Andorin A, Gourraud JB, Sacher F, Mabo P, Kim SH, Maeda S, Takahashi Y, Kamakura T, Aiba T, Juang JJ, Michowitz Y, Leshem E, Mizusawa Y, Arbelo E, Huang Z, Denjoy I, Giustetto C, Wijeyeratne YD, Mazzanti A, Brugada R, Casado-Arroyo R, Champagne J, Calo L, Sarquella-Brugada G, Tfelt-Hansen J, Priori SG, Takagi M, Veltmann C, Delise P, Corrado D, Behr ER, Gaita F, Yan GX, Brugada J, Leenhardt A, Wilde AAM, Brugada P, Kusano KF, Hirao K, Nam GB, Probst V, Belhassen B. Characteristics of Patients with Spontaneous Versus Drug-Induced Brugada Electrocardiogram: Sub-Analysis From the SABRUS. Circ Arrhythm Electrophysiol. 2023 01; 16(1):e011360.
-
Berberian JG. Hereditary Syndromes of Sudden Cardiac Death. Emerg Med Clin North Am. 2022 Nov; 40(4):651-662.
-
Corbisiero R, Muller D. The Gallant? system heart rhythm management device: making a connection. Future Cardiol. 2022 08; 18(8):605-614.
-
O'Hara RP, Binka E, Prakosa A, Zimmerman SL, Cartoski MJ, Abraham MR, Lu DY, Boyle PM, Trayanova NA. Personalized computational heart models with T1-mapped fibrotic remodeling predict sudden death risk in patients with hypertrophic cardiomyopathy. Elife. 2022 01 25; 11.
-
Ibrahim SH, Bilchick KC, Miller MS, Blazek OJ, Strickling JE, Elumogo C, Wharton RC, Patel P, Ondigi O, Brady WJ, Kwon Y, Mazimba S. Increased left and right atrial volume indices are associated with decreased survival times post-cardiac arrest. Resuscitation. 2022 01; 170:306-313.
-
Shirani J, Aurshiya R, Elshaikh A, Olenchock SA, Rowin EJ, Maron MS, Maron BJ. Low Risk of Hypertrophic Cardiomyopathy With Contemporary Management Strategies Implemented in Non-Referral Regional Community-Based Practices. Am J Cardiol. 2021 03 01; 142:130-135.
-
Wu KC, Wongvibulsin S, Tao S, Ashikaga H, Stillabower M, Dickfeld TM, Marine JE, Weiss RG, Tomaselli GF, Zeger SL. Baseline and Dynamic Risk Predictors of Appropriate Implantable Cardioverter Defibrillator Therapy. J Am Heart Assoc. 2020 10 20; 9(20):e017002.
-
Sassone B, Mandini S, Grazzi G, Mazzoni G, Myers J, Pasanisi G. Impact of COVID-19 Pandemic on Physical Activity in Patients With Implantable Cardioverter-Defibrillators. J Cardiopulm Rehabil Prev. 2020 09; 40(5):285-286.
-
Stabenau HF, Shen C, Zimetbaum P, Buxton AE, Tereshchenko LG, Waks JW. Global electrical heterogeneity associated with drug-induced torsades de pointes. Heart Rhythm. 2021 01; 18(1):57-62.